Published in Pharmacol Biochem Behav on December 01, 1996
Chronic tolerance to the social consequences of ethanol in adolescent and adult Sprague-Dawley rats. Neurotoxicol Teratol (2006) 1.14
Sensitization to social anxiolytic effects of ethanol in adolescent and adult Sprague-Dawley rats after repeated ethanol exposure. Alcohol (2010) 0.95
To breed or not to breed? Empirical evaluation of drug effects in adolescent rats. Int J Dev Neurosci (2008) 0.87
Impact of social isolation and enriched environment during adolescence on voluntary ethanol intake and anxiety in C57BL/6J mice. Physiol Behav (2014) 0.84
Early life adversity alters the developmental profiles of addiction-related prefrontal cortex circuitry. Brain Sci (2013) 0.81
Developmental neurotoxic effects of chlorpyrifos on acetylcholine and serotonin pathways in an avian model. Neurotoxicol Teratol (2008) 0.81
PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress. Dis Model Mech (2010) 0.80
An avian model for the reversal of neurobehavioral teratogenicity with neural stem cells. Neurotoxicol Teratol (2010) 0.79
Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model. Neurotoxicol Teratol (2009) 0.79
Prenatal cocaine exposure enhances responsivity of locus coeruleus norepinephrine neurons: role of autoreceptors. Neuroscience (2007) 0.78
Neurobehavioral teratogenicity of sarin in an avian model. Neurotoxicol Teratol (2009) 0.77
A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity. Neurotoxicol Teratol (2009) 0.76
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav (1986) 2.73
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Can social interaction be used to measure anxiety? Br J Pharmacol (1978) 2.50
Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia (1975) 2.46
The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods (1980) 2.26
Sex differences in animal tests of anxiety. Physiol Behav (1991) 1.74
The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav (1996) 1.39
Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety. Pharmacol Biochem Behav (1999) 1.26
5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res (1996) 1.25
Do lorazeam-induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation? Br J Clin Pharmacol (1982) 1.20
Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) (2001) 1.13
The reliability of the hole-board apparatus. Psychopharmacologia (1975) 1.11
Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav (1987) 1.11
Effects of ethanol and chlordiazepoxide on social interaction in rats [proceedings]. Br J Pharmacol (1976) 1.10
Studies on the role of ACTH and of 5-HT in anxiety, using an animal model. J Pharm Pharmacol (1978) 1.10
Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem (2000) 1.08
Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull (1992) 1.07
Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol (1993) 1.07
Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology (Berl) (1979) 1.03
Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) (1997) 1.03
Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol (1999) 1.00
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav (2001) 1.00
The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) (2001) 0.99
Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berl) (1986) 0.98
Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol (2004) 0.98
Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol (1989) 0.97
Interaction between effects of caffeine and lorazepam in performance tests and self-ratings. J Clin Psychopharmacol (1982) 0.97
The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br J Pharmacol (1985) 0.97
Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology (Berl) (1984) 0.95
Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav (1989) 0.95
Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.95
Corticosterone -- an anxiogenic or an anxiolytic agent? J Pharm Pharmacol (1979) 0.94
Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berl) (1999) 0.94
Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci (1998) 0.94
The anxiogenic action of benzodiazepine antagonists. Neuropharmacology (1982) 0.94
Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav (1998) 0.93
Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav Brain Res (1986) 0.93
Sedative effects of PK 9084 and PK 8165, alone and in combination with chlordiazepoxide. Br J Pharmacol (1983) 0.93
Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology (1984) 0.92
Mice lacking the cell adhesion molecule Thy-1 fail to use socially transmitted cues to direct their choice of food. Curr Biol (2000) 0.92
Effects of two anxiolytics on distraction, habituation and dishabitiuation. Pharmacol Biochem Behav (1977) 0.91
5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol (1994) 0.91
Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology (1997) 0.91
Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol (1987) 0.90
On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology (Berl) (1984) 0.90
The effects of piracetam on acquisition and retention of habituation [proceedings]. Br J Pharmacol (1977) 0.90
Regional differences in rat benzodiazepine binding in response to novelty and cat odour. Neuropharmacology (1994) 0.90
Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse. Psychopharmacology (Berl) (1983) 0.90
Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res (1984) 0.90
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) (1999) 0.89
A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol Biochem Behav (1979) 0.89
A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci (1997) 0.89
Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine. Pharmacol Biochem Behav (2001) 0.89
Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci (2001) 0.89
Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology (Berl) (1979) 0.88
Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology (2003) 0.88
Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology (Berl) (1981) 0.88
Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev (1985) 0.88
Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology (1985) 0.88
Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance. Psychopharmacology (Berl) (1982) 0.88
What can be learned from the effects of benzodiazepines on exploratory behavior? Neurosci Biobehav Rev (1985) 0.87
In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology (2001) 0.87
Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav (1992) 0.87
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav (1989) 0.86
5-HT and anxiety: promises and pitfalls. Pharmacol Biochem Behav (1986) 0.86
Benzodiazepines reduce gastric ulcers induced in rats by stress. Br J Pharmacol (1981) 0.86
The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci (2000) 0.85
Behavioural and neurochemical responses of male and female chicks to cat odour. Pharmacol Biochem Behav (1996) 0.85
Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors. Neuropharmacology (2000) 0.85
Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.85
Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci (1999) 0.84
Responders and nonresponders to cat odor do not differ in other tests of anxiety. Pharmacol Biochem Behav (1994) 0.84
Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum. Physiol Behav (1983) 0.84
The effects of tricyclic and 'atypical' antidepressants on spontaneous locomotor activity in rodents. Neurosci Biobehav Rev (1986) 0.83
Changes in tonic immobility and the GABA-benzodiazepine system in response to handling in the chick. Pharmacol Biochem Behav (1997) 0.83
The sensitivity of the rat corticosterone response to environmental manipulations and to chronic chlordiazepoxide treatment. Physiol Behav (1980) 0.83
Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (1981) 0.83
Dose tolerance to lorazepam develop with once weekly dosing? Br J Clin Pharmacol (1983) 0.83
Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors. J Neurol Neurosurg Psychiatry (1996) 0.83
The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol Behav (1985) 0.83
Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology (1994) 0.83
Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull (1988) 0.83
5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord (1979) 0.83
Does the sedation resulting from sleep deprivation and lorazepam cause similar cognitive deficits? Pharmacol Biochem Behav (1998) 0.83
Sex differences in benzodiazepine binding in the frontal cortex and amygdala of the rat 24 hours after restraint stress. Neurosci Lett (1996) 0.83
Raised [3H]-5-HT release and 45Ca2+ uptake in diazepam withdrawal: inhibition by baclofen. Pharmacol Biochem Behav (1992) 0.82
Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors? Neurosci Lett (1985) 0.82
Selective neurotoxin lesions of the lateral septum: changes in social and aggressive behaviours. Pharmacol Biochem Behav (1982) 0.82
The locus coeruleus noradrenergic system--evidence against a role in attention, habituation, anxiety and motor activity. Brain Res (1978) 0.82
The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology (1986) 0.82
The nature of lorazepam-induced amnesia. Psychopharmacology (Berl) (1984) 0.81
Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam. J Clin Psychopharmacol (1983) 0.81
Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence. Psychopharmacology (Berl) (1993) 0.81
Social isolation modifies nicotine's effects in animal tests of anxiety. Br J Pharmacol (2001) 0.81
Effects of chlorpromazine on exploration and habituation in the rat. Br J Pharmacol (1973) 0.81
Is benzodiazepine-induced amnesia due to deactivation of the left prefrontal cortex? Psychopharmacology (Berl) (2000) 0.81
Do different mechanisms underlie two anxiogenic effects of systemic nicotine? Behav Pharmacol (2003) 0.81
Behavioral consequences of antidepressant treatment in rodents. Neurosci Biobehav Rev (1986) 0.81
Behavioural pharmacology of benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.81